- Home
- SPCB vs ONCY Comparison
SPCB vs ONCY Comparison
Compare SPCB & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- ONCY
- Stock Information
- Founded
- SPCB 1988
- ONCY 1998
- Country
- SPCB Israel
- ONCY Canada
- Employees
- SPCB N/A
- ONCY N/A
- Industry
- SPCB Semiconductors
- ONCY Pharmaceuticals and Biotechnology
- Sector
- SPCB Technology
- ONCY Health Care
- Exchange
- SPCB Nasdaq
- ONCY Nasdaq
- Market Cap
- SPCB 53.3M
- ONCY 49.1M
- IPO Year
- SPCB N/A
- ONCY 1999
- Fundamental
- Price
- SPCB $9.72
- ONCY $0.91
- Analyst Decision
- SPCB Strong Buy
- ONCY Strong Buy
- Analyst Count
- SPCB 1
- ONCY 4
- Target Price
- SPCB $18.00
- ONCY $4.33
- AVG Volume (30 Days)
- SPCB 166.8K
- ONCY 1.4M
- Earning Date
- SPCB 08-14-2025
- ONCY 07-31-2025
- Dividend Yield
- SPCB N/A
- ONCY N/A
- EPS Growth
- SPCB N/A
- ONCY N/A
- EPS
- SPCB 1.89
- ONCY N/A
- Revenue
- SPCB $27,831,000.00
- ONCY N/A
- Revenue This Year
- SPCB $2.73
- ONCY N/A
- Revenue Next Year
- SPCB $22.87
- ONCY N/A
- P/E Ratio
- SPCB $5.16
- ONCY N/A
- Revenue Growth
- SPCB 2.90
- ONCY N/A
- 52 Week Low
- SPCB $2.55
- ONCY $0.33
- 52 Week High
- SPCB $18.95
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- SPCB 47.89
- ONCY 78.49
- Support Level
- SPCB $9.61
- ONCY $0.71
- Resistance Level
- SPCB $11.14
- ONCY $0.81
- Average True Range (ATR)
- SPCB 0.68
- ONCY 0.09
- MACD
- SPCB -0.22
- ONCY 0.02
- Stochastic Oscillator
- SPCB 17.44
- ONCY 90.48
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.